ITRMF · Iterum Therapeutics plc
$0.03
+0.00 (+0.00%)
At close · Jul 23
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 14, 2025
Market Cap
$1.38M
Shares
44.66M
Iterum Therapeutics plc Earnings Call Transcripts
Every quarterly earnings call for Iterum Therapeutics plc (ITRMF) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY25 · Q3
2025-11-14
Iterum Therapeutics plc Q3 FY2025 Earnings Call
Positive tone
Orlynda Commercial Launch
Sales Force / Field Operations
Specialty Distribution Partners
Revenue
$390,000
Diluted EPS
$-0.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Iterum Therapeutics plc Q2 FY2025 Earnings Call
Confident tone
ORLYNVAH Commercial Launch
Market Opportunity and Unmet Need
Commercial Strategy and Sales Coverage
Diluted EPS
$-0.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Iterum Therapeutics plc Q1 FY2025 Earnings Call
Positive tone
ORLYNVAH launch and commercialization
Competition
Market opportunity and unmet need
Diluted EPS
$-0.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-07
Iterum Therapeutics plc Q4 FY2024 Earnings Call
Positive tone
FDA approval and ORLYNVAH launch readiness
Cash runway and going concern
Uncomplicated urinary tract infection market opportunity
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Iterum Therapeutics plc Q3 FY2024 Earnings Call
Confident tone
Cash runway and exchangeable notes
Intellectual property and market exclusivity
Strategic alternatives / partnership process
Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Iterum Therapeutics plc Q2 FY2024 Earnings Call
Positive tone
FDA Advisory Committee and PDUFA
Capital and Cash Runway
Antibiotic Stewardship and Label
Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Iterum Therapeutics plc Q1 FY2024 Earnings Call
Confident tone
FDA resubmission and review of oral sulopenem NDA
Cash runway and financial position
Market positioning and competition for uncomplicated UTIs
Diluted EPS
$-0.46
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-29
Iterum Therapeutics plc Q4 FY2023 Earnings Call
Confident tone
NDA resubmission and FDA review
Financial position and cash runway
Uncomplicated UTI market opportunity
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-14
Iterum Therapeutics plc Q3 FY2023 Earnings Call
Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-11
Iterum Therapeutics plc Q2 FY2023 Earnings Call
Diluted EPS
$-0.95
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Iterum Therapeutics plc Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Iterum Therapeutics plc Q3 FY2022 Earnings Call
Diluted EPS
$-2.38
▼ 893.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-28
Iterum Therapeutics plc Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Iterum Therapeutics plc Q3 FY2021 Earnings Call
Diluted EPS
$0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-13
Iterum Therapeutics plc Q2 FY2021 Earnings Call
Diluted EPS
$0.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-14
Iterum Therapeutics plc Q1 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-12
Iterum Therapeutics plc Q4 FY2020 Earnings Call
Revenue
$*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–17 of 17 earnings calls